PRIORITY ELIGIBILITY CRITERIA FOR COVID-19 OUTPATIENT …

Over the course of the last year, the FDA has issued Emergency Use Authorizations (EUA) for multiple therapeutics for the treatment or prevention of COVID-19 in children and adults. Initially, the FDA authorized bamlanivimab, a single monoclonal …

  Emergency, Emergency use